Skip to content
10-Q

Quarterly Report

SKINOVATION PHARMACEUTICAL INCORPORATED

0001554795-22-000186

← back to feed
Filed
May 13, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 13, 2022 708K sh
Cash And Equivalents Q1 2022 · Mar 31, 2022 $112
Cash And Equivalents Q1 2022 · Dec 31, 2021 $222
Cash And Equivalents Q1 2022 · Mar 31, 2021 $1.85K
Cash And Equivalents Q1 2022 · Dec 31, 2020 $3.55K
Current Liabilities Q1 2022 · Mar 31, 2022 $388.15K
Current Liabilities Q1 2022 · Dec 31, 2021 $377.81K
Total Liabilities Q1 2022 · Mar 31, 2022 $388.15K
Total Liabilities Q1 2022 · Dec 31, 2021 $377.81K
Current Assets Q1 2022 · Mar 31, 2022 $112
Current Assets Q1 2022 · Dec 31, 2021 $222
Total Assets Q1 2022 · Mar 31, 2022 $112
Total Assets Q1 2022 · Dec 31, 2021 $222
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$1.7K
Stockholders Equity Q1 2022 · Mar 31, 2021 −$355.15K
Stockholders Equity Q1 2022 · Dec 31, 2020 −$345.14K
Sga Expense Q1 2022 · Mar 31, 2021 $5.4K
Net Income Q1 2022 · Mar 31, 2021 −$10.01K
Operating Income Q1 2022 · Mar 31, 2021 −$5.4K